GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (WBO:BAVA) » Definitions » Other Stockholders Equity

Bavarian Nordic A/S (WBO:BAVA) Other Stockholders Equity : €23.3 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bavarian Nordic A/S Other Stockholders Equity?

Bavarian Nordic A/S's Other Stockholders Equity for the quarter that ended in Mar. 2024 was €23.3 Mil.

Bavarian Nordic A/S's quarterly Other Stockholders Equity increased from Sep. 2023 (€17.7 Mil) to Dec. 2023 (€30.9 Mil) but then declined from Dec. 2023 (€30.9 Mil) to Mar. 2024 (€23.3 Mil).

Bavarian Nordic A/S's annual Other Stockholders Equity increased from Dec. 2021 (€11.1 Mil) to Dec. 2022 (€19.3 Mil) and increased from Dec. 2022 (€19.3 Mil) to Dec. 2023 (€30.9 Mil).

Bavarian Nordic A/S Other Stockholders Equity Historical Data

The historical data trend for Bavarian Nordic A/S's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Other Stockholders Equity Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.01 8.68 11.05 19.29 30.92

Bavarian Nordic A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.82 18.94 17.67 30.92 23.31

Bavarian Nordic A/S Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Bavarian Nordic A/S Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic A/S (WBO:BAVA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (WBO:BAVA) » Definitions » Other Stockholders Equity
Comparable Companies
OCSE:GUBRA OCSE:PEG OCSE:ALK B OCSE:ZEAL OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
BVNRY:USA BVNKF:USA BAVAc:UK 0DPB:UK BAVA:Denmark BV3:Germany
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Website
https://www.bavarian-nordic.com
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (WBO:BAVA) Headlines

No Headlines